Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by: Teva Czech Industries sro, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7474-89
Published March 9, 2016 · Recall initiated: December 21, 2015
Summary
FDA records drug Class II recall D-0732-2016, published March 9, 2016 and initiated December 21, 2015. Recalling firm: Teva North America; Status: Terminated; Reported quantity: 1,895 bottles; Lot: Lot # 3A404012V, Exp. 4/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: low test results at the 18 month time-point
What to do
Voluntary: Firm initiated · Letter
Get an email if CAPECITABINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CAPECITABINE
- Manufacturer
- Teva North America
- Distributor
- Nationwide
- Lot
- Lot # 3A404012V, Exp. 4/2016
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDA0.9% Sodium Chloride Irrigation, USP, 500 mL bottle, Rx Only, Baxter Healthcare Corporation, Deerfield, ILMarch 9, 2016
- FDAsulfur8 medicated LIGHT FORMULA (sulfur) anti-dandruff hair & scalp conditioner, 2%, packaged in a) 2 OZ (57g)March 9, 2016
- FDAThyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only,March 9, 2016
- FDAAlendronate Sodium Tablets, USP, 70 mg*, 4-count blisters per carton, Rx only, Manufactured by: SunMarch 9, 2016
- FDAThyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only,March 9, 2016
- FDAApple Caramel Almond Tea, Bag Size - 2lbs Minimum, Bulk Packaging, Item No. FB-004March 9, 2016
Questions about this recall
Was Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by: Teva Czech Industries sro, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7474-89 recalled?
Yes. FDA published recall D-0732-2016 on March 9, 2016. Reported hazard: Failed Dissolution Specifications: low test results at the 18 month time-point
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CAPECITABINE.